Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review.

Couttas, Timothy A; Jieu, Beverly; Rohleder, Cathrin; Leweke, F Markus

Couttas, Timothy A; Jieu, Beverly; Rohleder, Cathrin; Leweke, F Markus.

Afiliação

Couttas TA; Brain and Mind Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Jieu B; Brain and Mind Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Rohleder C; Brain and Mind Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.
Leweke FM; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Front Psychiatry ; 13: 885904, 2022.

Article em En | MEDLINE | ID: mdl-35711577

Palavras-chave

LC-MS/MS; biomarkers; clinically high risk patients; first-episode psychosis (FEP); lipidomics; metabolomics; peripheral tissue; psychosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google